Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
31°
Sunny
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Marker Therapeutics, Inc. - Common Stock
(NQ:
MRKR
)
0.9990
-0.0010 (-0.10%)
Streaming Delayed Price
Updated: 3:29 PM EDT, Apr 7, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Marker Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
Crude Oil Drops Sharply; Chinook Therapeutics Shares Spike Higher
June 12, 2023
U.S. stocks traded higher midway through trading, with Dow Jones gaining over 40 points on Monday. The Dow traded up 0.12% to 33,919.07 while the NASDAQ rose 0.49% to 13,323.71. The S&P 500, also rose,...
Via
Benzinga
Marker Therapeutics Inc. (NASDAQ: MRKR) Leading the Way in Friday Trading Based on Percentage Gain
June 09, 2023
Via
Investor Brand Network
Why American Software Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session
June 09, 2023
Gainers Advanced Health Intelligence Ltd. (NASDAQ: AHI) shares jumped 144.5% to $0.7827.
Via
Benzinga
Why Mallinckrodt Shares Are Trading Lower By 20%; Here Are 20 Stocks Moving Premarket
June 05, 2023
Gainers Forza X1, Inc. (NASDAQ: FRZA) shares rose 85.6% to $2.32 in pre-market trading after the company tweeted Friday 'Get ready for something extraordinary! Stay tuned!'
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
June 05, 2023
It's time to start the week off right with a breakdown of the biggest pre-market stock movers worth watching on Monday morning!
Via
InvestorPlace
Crude Oil Down 2%; Donaldson Shares Drop Following Q3 Results
May 31, 2023
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping over 100 points on Wednesday. The Dow traded down 0.34% to 32,929.04 while the NASDAQ fell 0.30% to 12,978.20. The S&P...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
May 31, 2023
Via
Benzinga
Why Capri Holdings Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
May 31, 2023
Gainers Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS) shares jumped 143% to $0.45 after the company announced it received agreement from the FDA on its proposed single confirmatory Phase 3 study of...
Via
Benzinga
MARK Stock Alert: AI News Causes Volatility for Remark Shares
May 31, 2023
Remark (MARK) stock is moving on Wednesday with investors learning about a contract with the Rio De Janeiro police department.
Via
InvestorPlace
Nasdaq Down 100 Points; Advance Auto Parts Earnings Miss Views
May 31, 2023
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping over 100 points on Wednesday. The Dow traded down 0.82% to 32,773.27 while the NASDAQ fell 0.86% to 12,905.49. The...
Via
Benzinga
Why Is Marker Therapeutics (MRKR) Stock Up 27% Today?
May 31, 2023
Marker Therapeutics (MRKR) stock is rising higher on Wednesday as investors react to positive pre-clinical news from the company.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
May 31, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
May 04, 2023
Via
Benzinga
Marker Therapeutics (NASDAQ: MRKR) Announces Leadership Transition and Strategic Partnership with CellReady to Strengthen Financial Position Through 2025
May 01, 2023
Houston-based Marker Therapeutics, Inc. (Nasdaq: MRKR) operates as a clinical-stage company focused on developing advanced T cell-based immunotherapies for hematological
Via
Spotlight Growth
12 Health Care Stocks Moving In Monday's Pre-Market Session
May 01, 2023
Via
Benzinga
Why Legend Biotech Stock Is Having Its Best Month Yet
April 25, 2023
With the biotech market’s focus back on treatments for cancer and other life-threatening diseases, Legend has now tripled off its bottom to a record high.
Via
MarketBeat
12 Health Care Stocks Moving In Thursday's Intraday Session
March 23, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 22, 2023
Via
Benzinga
Why Satsuma Pharmaceuticals Shares Are Trading Higher By 94%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 17, 2023
Gainers ContraFect Corporation (NASDAQ: CFRX) shares surged 213% to $2.82.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
March 07, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
January 26, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 25, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
January 16, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
December 29, 2022
On Thursday, 116 companies set new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
November 23, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 23, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 22, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
October 20, 2022
Gainers Nuwellis (NASDAQ:NUWE) stock rose 13.9% to $0.28 during Thursday's after-market session. The company's market cap stands at $8.9 million.
Via
Benzinga
Why Target Shares Are Trading Lower By 14%? Here Are 56 Stocks Moving In Wednesday's Mid-Day Session
November 16, 2022
Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares jumped 109% to $0.2115 after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process.
Via
Benzinga
Why Minerva Neurosciences Shares Dipped By Around 70%; Here Are 90 Biggest Movers From Yesterday
October 18, 2022
Gainers Acorda Therapeutics, Inc. (NASDAQ: ACOR) surged 163.8% to close at $0.8970 on Monday after the company announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.